Results 31 to 40 of about 2,070,589 (168)

Effect of Intravitreal Injection of Dexamethasone 0.7 mg (Ozurdex®) on Intraocular Pressure in Patients with Macular Edema

Ophthalmic Research, 2015
<b><i>Background:</i></b> To evaluate the effect of Ozurdex® on intraocular pressure in patients with macular edema alone (group 1) or associated with glaucoma or ocular hypertension (group 2). <b><i>Methods:</i></b> A clinical, retrospective, observational, comparative study included 92 eyes with macular
Stefania, Mazzarella, Carlos, Mateo, Silvia, Freixes, Anniken, Burés-Jelstrup, Jose, Rios, Rafael, Navarro, Jose, García-Arumí, Borja, Corcóstegui, Elena, Arrondo   +8 more
openaire   +2 more sources

Dexamethasone Implant Migration through an Iris Coloboma

Case Reports in Ophthalmology, 2020
Ozurdex® 0.7 mg (dexamethasone 0.7 mg implant, Allergan, Dublin, Ireland), an intravitreal biodegradable implant, is indicated for cystoid macular edema due to various causes.
Yoav Glidai, Shulamit Schwartz, Eyal Cohen   +2 more
doaj   +1 more source

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 [PDF]

, 2016
Induction therapy for childhood acute lymphoblastic leukemia (ALL) traditionally includes prednisone; yet, dexamethasone may have higher antileukemic potency, leading to fewer relapses and improved survival.
Stanulla, Martin, Kremens, Bernhard, Beier, Rita, Greiner, Jeanette, Ratei, Richard, Conter, Valentino, Basso, Giuseppe, Parasole, Rosanna, von Stackelberg, Arend, Lo Nigro, Luca, Schrappe, Martin, Kulozik, Andreas E, Attarbaschi, Andishe, Harbott, Jochen, Caruso, Roberta, Mann, Georg, Cazzaniga, Giovanni, Valsecchi, Maria Grazia, Niggli, Felix, Bartram, Claus R, Zimmermann, Martin, Barisone, Elena, Silvestri, Daniela, Möricke, Anja, LOCATELLI, FRANCO, Lo Nigro L., Zimmermann M, Ratei R, Valsecchi MG, Barisone E., Harbott J, Caruso R, Kremens B, Zimmermann M., Stanulla M., Basso G., Beier R., von Stackelberg A., Basso G, Rossig C., Schrappe M, Attarbaschi A, Rössig C, Kremens B., Bartram C. R., Cazzaniga G., Parasole R, Niggli F., Beier R, Moricke A., Kulozik AE, Silvestri D., Locatelli F., Silvestri D, Stanulla M, von Stackelberg A, Ratei R., Attarbaschi A., Parasole R., Locatelli F, Lo Nigro L, Biondi A, Caruso R., Schrappe M., Möricke A, Barisone E, BIONDI, ANDREA, Kulozik A. E., Bartram CR, Valsecchi M. G., Cazzaniga G, Aricò M, Greiner J., Rössig, Claudia, Mann G, Mann G., Niggli F, Greiner J, Conter V., Biondi A., Arico M., Aricò, Maurizio, Conter V, Harbott J.   +83 more
core   +2 more sources

Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial [PDF]

, 2022
Objective To investigate the effects of one and two doses of intravenous dexamethasone in patients after total knee arthroplasty.Design Randomised, blinded, placebo controlled trial with follow-up at 90 days.Setting Five Danish hospitals, September 2018 ...
Jensen, Mette Skov, Bagger, Jens, Nørskov, Anders Kehlet, Pallesen, Marie Jøhnk, Lindberg-Larsen, Martin, Hägi-Pedersen, Daniel, Overgaard, Søren, Pedersen, Niels Anker, Ammitzboell, Mette, Lindholm, Peter, Lindberg-Larsen, Martin; id_orcid, Vinstrup, Louise Ørts, Gasbjerg, Kasper Smidt, Mathiesen, Ole, Schrøder, Henrik Morville, Laursen, Christina Cleveland, Lunn, Troels Haxholdt, Jakobsen, Janus Christian; id_orcid, Jakobsen, Karina, Holmqvist, Majken, Brorson, Stig, Thybo, Kasper Højgaard, Jakobsen, Janus Christian, Majken Holmqvist, Janus Christian Jakobsen, Troels Haxholdt Lunn, Karina Jakobsen, Daniel Hägi-Pedersen, Anders Kehlet Nørskov, Kasper Højgaard Thybo, Søren Overgaard, Mette Skov Jensen, Martin Lindberg-Larsen, Stig Brorson, Peter Lindholm, Henrik Morville Schrøder, Marie Jøhnk Pallesen, Mette Ammitzboell, Ole Mathiesen, Niels Anker Pedersen, Kasper Smidt Gasbjerg, Christina Cleveland Laursen, Jens Bagger, Louise Ørts Vinstrup   +43 more
core   +1 more source

A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal implant (Ozurdex®): an emphasis on combination therapy. [PDF]

Journal of Clinical Ophthalmology, 2018
Introduction: Retinal Vein Occlusion (RVO) is the second commonest retinal vascular pathology after diabetic retinopathy. Ozurdex is a sustained-release 0.7 mg dexamethasone intravitreal implant which has been approved to treat adults with RVO, non-infectious posterior uveitis and pseudophakic patients with diabetic macular oedema. We aim to assess its
Shahina Ahmed, Hani Hasan, Mohamed Elashry   +2 more
openaire   +1 more source

The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema

Diagnostics, 2020
Background: The aim of this study was to compare the therapeutic effect of intravitreal treatment with ranibizumab and dexamethasone using specific swept-source optical coherence tomography retinal biomarkers in patients with diabetic macular edema (DME).
Ida Ceravolo, Giovanni William Oliverio, Angela Alibrandi, Ahsan Bhatti, Luigi Trombetta, Robert Rejdak, Mario Damiano Toro, Costantino John Trombetta   +7 more
doaj   +1 more source

Comparative characteristics of the outcomes of the use of multidirectional intravitreal pharmacotherapy in the treatment of diabetic macular edema

Офтальмохирургия, 2021
Purpose. To conduct a comparative analysis of the effectiveness of intravitreal injection of dexamethasone-containing implant and aflibercept in macular edema in patients with diabetes mellitus.Material and methods.
M. M. Bikbov, K. I. Kudoyarova, R. M. Zainullin, T. R. Gilmanshin   +3 more
doaj   +1 more source

Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker [PDF]

, 2014
PURPOSE: To study the efficacy of a single 0.7 mg dexamethasone intravitreal implant in vitrectomized eyes with refractory macular edema secondary to combined cataract extraction and macular pucker removal.
Alessio, C., Recchimurzo, F., BOSCIA, Francesco, Furino, C, Sborgia, N   +4 more
core   +2 more sources

Dexamethasone 0.7 mg Implant for the Treatment of Recalcitrant Radiation Maculopathy after Proton Radiotherapy for Carcinoma of the Maxillary Sinus 

Journal of Ocular Diseases and Therapeutics, 2014
Purpose: To report the efficacy of dexamethasone 0.7 mg intravitreal implant in recalcitrant radiation retinopathy. Method: Retrospective case report of a single case describing successful treatment of radiation retinopathy with dexamethasone 0.7 mg intravitreal implant following multiple failed attempts with both bevacizumab and focal laser.
Justin B. Hellman, Jose M Garcia-Gonzalez, Shawn Lewis, Seenu M. Hariprasad   +3 more
openaire   +1 more source

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant

Mediators of Inflammation, 2014
Aims. This retrospective analysis was aimed at evaluating the effectiveness of treatment of persistent diabetic macular edema with intravitreal injections of 0.7 mg dexamethasone implant Ozurdex.
Dominik Zalewski, Dorota Raczyńska, Krystyna Raczyńska   +2 more
doaj   +1 more source